These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 35175505)
1. Mutation of Beclin1 acetylation site at K414 alleviates high glucose-induced podocyte impairment in the early stage of diabetic nephropathy by inhibiting hyperactivated autophagy. Xu J; Deng Y; Ke Y; Zhu Y; Wang P; Yu Q; Li C; Shi B Mol Biol Rep; 2022 May; 49(5):3919-3926. PubMed ID: 35175505 [TBL] [Abstract][Full Text] [Related]
2. Curcumin alleviates diabetic nephropathy via inhibiting podocyte mesenchymal transdifferentiation and inducing autophagy in rats and MPC5 cells. Tu Q; Li Y; Jin J; Jiang X; Ren Y; He Q Pharm Biol; 2019 Dec; 57(1):778-786. PubMed ID: 31741405 [No Abstract] [Full Text] [Related]
3. Integrated Network Pharmacology and Cellular Assay to Explore the Mechanisms of Selenized Tripterine Phytosomes (Se@Tri-PTs) Alleviating Podocyte Injury in Diabetic Nephropathy. Zhu S; Liu Q; Chang Y; Luo C; Zhang X; Sun S Curr Pharm Des; 2023; 29(38):3073-3086. PubMed ID: 37961864 [TBL] [Abstract][Full Text] [Related]
4. Spironolactone alleviates diabetic nephropathy through promoting autophagy in podocytes. Dong D; Fan TT; Ji YS; Yu JY; Wu S; Zhang L Int Urol Nephrol; 2019 Apr; 51(4):755-764. PubMed ID: 30734886 [TBL] [Abstract][Full Text] [Related]
5. Mutation of the novel acetylation site at K414R of BECN1 is involved in adipocyte differentiation and lipolysis. Li C; Xu J; Yu Q; Wang P; Dong B; Shen L; Wang Q; Li S; Yang Y; Deng Y J Cell Mol Med; 2021 Jul; 25(14):6855-6863. PubMed ID: 34085745 [TBL] [Abstract][Full Text] [Related]
6. Sarsasapogenin restores podocyte autophagy in diabetic nephropathy by targeting GSK3β signaling pathway. Li XZ; Jiang H; Xu L; Liu YQ; Tang JW; Shi JS; Yu XJ; Wang X; Du L; Lu Q; Li CL; Liu YW; Yin XX Biochem Pharmacol; 2021 Oct; 192():114675. PubMed ID: 34252407 [TBL] [Abstract][Full Text] [Related]
7. Tongluo Digui decoction treats renal injury in diabetic rats by promoting autophagy of podocytes. Han J; Zhang Y; Shi X; Peng Z; Xing Y; Pang X J Tradit Chin Med; 2021 Feb; 41(1):125-132. PubMed ID: 33522205 [TBL] [Abstract][Full Text] [Related]
8. Triptolide inhibits oxidative stress and inflammation via the microRNA-155-5p/brain-derived neurotrophic factor to reduce podocyte injury in mice with diabetic nephropathy. Gao J; Liang Z; Zhao F; Liu X; Ma N Bioengineered; 2022 May; 13(5):12275-12288. PubMed ID: 35603354 [TBL] [Abstract][Full Text] [Related]
9. Mangiferin prevents diabetic nephropathy progression and protects podocyte function via autophagy in diabetic rat glomeruli. Wang X; Gao L; Lin H; Song J; Wang J; Yin Y; Zhao J; Xu X; Li Z; Li L Eur J Pharmacol; 2018 Apr; 824():170-178. PubMed ID: 29444469 [TBL] [Abstract][Full Text] [Related]
10. Astragaloside IV Attenuates High-Glucose-Induced Impairment in Diabetic Nephropathy by Increasing Klotho Expression via the NF- He J; Cui J; Shi Y; Wang T; Xin J; Li Y; Shan X; Zhu Z; Gao Y J Diabetes Res; 2023; 2023():7423661. PubMed ID: 37261217 [TBL] [Abstract][Full Text] [Related]
11. Connexin 43‑autophagy loop in the podocyte injury of diabetic nephropathy. Ji J; Zhao Y; Na C; Yang M; Zhu X; Shi H; Gan W; Zhang A Int J Mol Med; 2019 Nov; 44(5):1781-1788. PubMed ID: 31545399 [TBL] [Abstract][Full Text] [Related]
12. [Effect of electroacupuncture on renal function and expression of autophagy-related proteins in kidney of rats with diabetic nephropathy]. Huang H; Chen L; Wu H; Jin JS Zhen Ci Yan Jiu; 2022 Feb; 47(2):108-14. PubMed ID: 35218619 [TBL] [Abstract][Full Text] [Related]
13. Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats. Chen J; Chen Y; Luo Y; Gui D; Huang J; He D Eur J Pharmacol; 2014 Aug; 736():86-94. PubMed ID: 24809932 [TBL] [Abstract][Full Text] [Related]
14. Down-regulation of Risa improves podocyte injury by enhancing autophagy in diabetic nephropathy. Su PP; Liu DW; Zhou SJ; Chen H; Wu XM; Liu ZS Mil Med Res; 2022 May; 9(1):23. PubMed ID: 35614465 [TBL] [Abstract][Full Text] [Related]
15. LncRNA Hoxb3os protects podocytes from high glucose-induced cell injury through autophagy dependent on the Akt-mTOR signaling pathway. Jin J; Gong J; Zhao L; Li Y; He Q Acta Biochim Pol; 2021 Oct; 68(4):619-625. PubMed ID: 34648253 [TBL] [Abstract][Full Text] [Related]
16. Impaired Podocyte Autophagy Exacerbates Proteinuria in Diabetic Nephropathy. Tagawa A; Yasuda M; Kume S; Yamahara K; Nakazawa J; Chin-Kanasaki M; Araki H; Araki S; Koya D; Asanuma K; Kim EH; Haneda M; Kajiwara N; Hayashi K; Ohashi H; Ugi S; Maegawa H; Uzu T Diabetes; 2016 Mar; 65(3):755-67. PubMed ID: 26384385 [TBL] [Abstract][Full Text] [Related]
17. Intravenous injection of human umbilical cord-derived mesenchymal stem cells ameliorates not only blood glucose but also nephrotic complication of diabetic rats through autophagy-mediated anti-senescent mechanism. Li X; Guo L; Chen J; Liang H; Liu Y; Chen W; Zhou L; Shan L; Wang H Stem Cell Res Ther; 2023 May; 14(1):146. PubMed ID: 37248536 [TBL] [Abstract][Full Text] [Related]
18. Silencing of PFKFB3 protects podocytes against high glucose‑induced injury by inducing autophagy. Zhu Z; Liu Q; Sun J; Bao Z; Wang W Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34490476 [TBL] [Abstract][Full Text] [Related]
19. miR-1187 induces podocyte injury and diabetic nephropathy through autophagy. Chen B; He Q Diab Vasc Dis Res; 2023; 20(3):14791641231172139. PubMed ID: 37208852 [TBL] [Abstract][Full Text] [Related]
20. Exosome secreted from adipose-derived stem cells attenuates diabetic nephropathy by promoting autophagy flux and inhibiting apoptosis in podocyte. Jin J; Shi Y; Gong J; Zhao L; Li Y; He Q; Huang H Stem Cell Res Ther; 2019 Mar; 10(1):95. PubMed ID: 30876481 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]